Methods for treating HCV
The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Mensing, Sven Podsadecki, Thomas J Wang, Tianli Dutta, Sandeep Lin, Chih-Wei Bernstein, Barry M Liu, Wei Menon, Rajeev M Campbell, Andrew Awni, Walid M |
description | The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016291154BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016291154BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016291154BB23</originalsourceid><addsrcrecordid>eNrjZJDwTS3JyE8pVkjLL1IoKUpNLMnMS1fwcA7jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoZmRpaGhqYmTk5GxkQqAwCMcSMR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods for treating HCV</title><source>esp@cenet</source><creator>Mensing, Sven ; Podsadecki, Thomas J ; Wang, Tianli ; Dutta, Sandeep ; Lin, Chih-Wei ; Bernstein, Barry M ; Liu, Wei ; Menon, Rajeev M ; Campbell, Andrew ; Awni, Walid M</creator><creatorcontrib>Mensing, Sven ; Podsadecki, Thomas J ; Wang, Tianli ; Dutta, Sandeep ; Lin, Chih-Wei ; Bernstein, Barry M ; Liu, Wei ; Menon, Rajeev M ; Campbell, Andrew ; Awni, Walid M</creatorcontrib><description>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211021&DB=EPODOC&CC=AU&NR=2016291154B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211021&DB=EPODOC&CC=AU&NR=2016291154B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Mensing, Sven</creatorcontrib><creatorcontrib>Podsadecki, Thomas J</creatorcontrib><creatorcontrib>Wang, Tianli</creatorcontrib><creatorcontrib>Dutta, Sandeep</creatorcontrib><creatorcontrib>Lin, Chih-Wei</creatorcontrib><creatorcontrib>Bernstein, Barry M</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><creatorcontrib>Menon, Rajeev M</creatorcontrib><creatorcontrib>Campbell, Andrew</creatorcontrib><creatorcontrib>Awni, Walid M</creatorcontrib><title>Methods for treating HCV</title><description>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDwTS3JyE8pVkjLL1IoKUpNLMnMS1fwcA7jYWBNS8wpTuWF0twMKm6uIc4euqkF-fGpxQWJyal5qSXxjqFGBoZmRpaGhqYmTk5GxkQqAwCMcSMR</recordid><startdate>20211021</startdate><enddate>20211021</enddate><creator>Mensing, Sven</creator><creator>Podsadecki, Thomas J</creator><creator>Wang, Tianli</creator><creator>Dutta, Sandeep</creator><creator>Lin, Chih-Wei</creator><creator>Bernstein, Barry M</creator><creator>Liu, Wei</creator><creator>Menon, Rajeev M</creator><creator>Campbell, Andrew</creator><creator>Awni, Walid M</creator><scope>EVB</scope></search><sort><creationdate>20211021</creationdate><title>Methods for treating HCV</title><author>Mensing, Sven ; Podsadecki, Thomas J ; Wang, Tianli ; Dutta, Sandeep ; Lin, Chih-Wei ; Bernstein, Barry M ; Liu, Wei ; Menon, Rajeev M ; Campbell, Andrew ; Awni, Walid M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016291154BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Mensing, Sven</creatorcontrib><creatorcontrib>Podsadecki, Thomas J</creatorcontrib><creatorcontrib>Wang, Tianli</creatorcontrib><creatorcontrib>Dutta, Sandeep</creatorcontrib><creatorcontrib>Lin, Chih-Wei</creatorcontrib><creatorcontrib>Bernstein, Barry M</creatorcontrib><creatorcontrib>Liu, Wei</creatorcontrib><creatorcontrib>Menon, Rajeev M</creatorcontrib><creatorcontrib>Campbell, Andrew</creatorcontrib><creatorcontrib>Awni, Walid M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mensing, Sven</au><au>Podsadecki, Thomas J</au><au>Wang, Tianli</au><au>Dutta, Sandeep</au><au>Lin, Chih-Wei</au><au>Bernstein, Barry M</au><au>Liu, Wei</au><au>Menon, Rajeev M</au><au>Campbell, Andrew</au><au>Awni, Walid M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods for treating HCV</title><date>2021-10-21</date><risdate>2021</risdate><abstract>The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the treatment comprises administering at least two direct acting antiviral agents to a subject with HCV infection, wherein the treatment lasts for 12 weeks and does not include administration of either interferon or ribavirin, and said at least two direct acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2016291154BB2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Methods for treating HCV |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Mensing,%20Sven&rft.date=2021-10-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016291154BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |